Impulsonics utilizes acoustic waves to automate cell passaging, a critical and time-consuming process in cell culture that traditionally requires complex machinery. By simplifying this operation into a compact benchtop unit, the company enhances lab efficiency and scalability for biotechnology applications.
Funding
$550K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cell passaging, the process of transferring cells to new vessels for continued growth, is a time-consuming and often complex procedure in cell culture. Traditional methods rely on large, intricate machinery, limiting scalability and accessibility for many biotechnology labs.
Solution
Impulsonics simplifies cell passaging by using acoustic waves to manipulate cells directly within their culture media. Their benchtop unit automates the process of moving cells to new vessels, eliminating the need for complex, multi-step systems. By harnessing acoustic waves, Impulsonics enables in-situ cell manipulation, reducing the risk of errors and contamination while improving lab efficiency. This approach makes cell passaging automation accessible to labs of all sizes, allowing researchers to focus on higher-level tasks such as experiment design and data analysis.
Target Audience
Impulsonics targets biotechnology labs, research institutions, and pharmaceutical companies involved in cell culture, drug discovery, and cell therapies.
Features
- Compact, benchtop unit for automated cell passaging
- Acoustic wave technology for gentle and precise cell manipulation
- In-situ cell processing within culture media, minimizing disturbance
- Scalable automation solution suitable for various lab sizes
- Simplified workflow compared to traditional cell passaging methods